Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-17-000008

Chief Executive Officer gave up 70,392 shares (to pay taxes)

  • Chief Executive Officer acquired 197,079 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kim Jong Joseph · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2017-03-09 Exercise or conversion : show line 1 in the form +57,334 2,021,944 D
2017-03-09 Shares withheld for taxes : show line 2 in the form −17,787 $6.61 $117,572 2,004,157 D
2017-03-10 Exercise or conversion : show line 3 in the form +139,745 2,143,902 D
2017-03-10 Shares withheld for taxes : show line 4 in the form −52,605 $6.68 $351,401 2,091,297 D

Table II: Derivative

3 lines
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2017-03-09 Exercise or conversion : show line 5 in the form Restricted Stock Unit −57,334 57,334 114,666 D
2017-03-10 Grant or award : show line 6 in the form Common Stock Option +43,150 $6.68 $288,242 $6.68 2027-03-10 43,150 43,150 D
2017-03-10 Grant or award : show line 7 in the form Restricted Stock Unit +317,100 317,100 317,100 D
Loading xslF345X03/wf-form4_148944129682642.xml…